Antibodies That Inhibit Binding of Plasmodium falciparum-Infected Erythrocytes to Chondroitin Sulfate A and to the C Terminus of Merozoite Surface Protein 1 Correlate with Reduced Placental Malaria in Cameroonian Women

Infection and Immunity

Volumn 72, Issue 3, 2004, Pages 1603-1607

  Taylor, Diane Wallace ^a   Zhou, Aniong ^d   Marsillio, Lauren E ^a   Thuita, Lucy W ^a   Leke, Efua B ^a   Branch, OraLee ^b   Gowda, D Channe ^c   Long, Carole ^e   Leke, Rose F G ^f  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d AZ DataClinic Inc   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 4 SULFATE; CIRCUMSPOROZOITE PROTEIN; LIVER ANTIGEN; LIVER STAGE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIBODY; PARASITE ANTIGEN; PROTEIN ANTIBODY; RING INFECTED ERYTHROCYTE SURFACE ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

ADULT; ARTICLE; CAMEROON; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MALARIA; NONHUMAN; PARASITEMIA; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; CAMEROON; CASE-CONTROL STUDIES; CHONDROITIN SULFATES; ERYTHROCYTES; FEMALE; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

EID: 1342281342     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.3.1603-1607.2004     Document Type: Article

References (25)

1. Achur, R. N., M. Valiyaveettil, A. Alkhalil, C. F. Ockenhouse, and D. C. Gowda. 2000. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. J. Biol. Chem. 275:40344-40356.
2. Alkhalil, A., R. N. Achur, M. Valiyaveettil, C. F. Ockenhouse, and D. C. Gowda. 2000. Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. J. Biol. Chem. 275:40357-40364.
3. Astagneau, P., R. W. Steketee, J. J. Wirima, C. O. Khoromana, and P. Millet. 1994. Antibodies to ring-infected erythrocyte surface antigen (Pf155/RESA) protect against P. falciparum parasitemia in highly exposed multigravidas women in Malawi. Acta Trop. 57:317-325.
4. Beck, S., F. P. Mockenhaupt, U. Bienzle, T. A. Eggelte, W. N. Thompson, and S. K. 2001. Multiplicity of Plasmodium falciparum infection in pregnancy. Am. J. Trop. Med. Hyg. 65:631-636.
5. Blackman, M. J., T. J. Scott-Finnigan, S. Shai, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-393.
6. Brabin, B. J. 1983. An analysis of malaria in pregnancy in Africa. Bull. W. H. O. 61:1005-1016.
7. Branch, O. H., V. Udhayakumar, A. W. Hightower, A. J. Oloo, W. A. Hawley, B. L. Nahlen, P. B. Bloland, D. C. Kaslow, and A. Lal. 1998. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemias, and anemia. Am. J. Trop. Med. Hyg. 58:211-219.
8. Deloron, P., R. W. Steketee, G. H. Campbell, F. Peyron, D. C. Kaseje, and A. D. Brandling-Bennett. 1989. Serological reactivity to the ring-infected erythrocyte surface antigen and circumsporozoite protein in gravid and nulligravid women infected with Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 83:58-62.
9. Fievet, N., M. Cot, C. Chougnet, B. Maubert, J. Bickii, B. Dubois, j. Y. Le Hesran, Y. Frobert, F. Migot, F. Romain, et al. 1995. Malaria and pregnancy in Cameroonian primigravidae: humoral and cellular immune responses to Plasmodium falciparum blood-stage antigens. Am. J. Trop. Med. Hyg. 53:612-617.
10. Fried, M., and P. E. Duffy. 1996. Adherence of Plasmodium falciparum to CSA in the human placenta. Science 272:1502-1504.
11. Fried, M., and P. E. Duffy. 1998. Maternal malaria and parasite adhesion. J. Mol. Med. 76:162-171.
12. Fried, M., F. Nosten, A. Brockman, B. J. Brabin, and P. E. Duffy. 1998. Maternal antibodies block malaria. Nature 395:851-852.
13. Galbraith, R. M., W. P. Faulk, G. M. P. Galbraith, T. W. Holbrook, and R. S. Bray. 1980. The human materno-foetal relationship in malaria: I. Identification of pigment and parasites in the placenta. Trans. R. Soc. Trop. Med. Hyg. 74:52-60.
14. Guevara Patino, J. A., A. A. Holder, J. S. McBride, and M. J. Blackman. 1997. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186:1689-1699.
15. Holder, A. A., J. A. Guevara Patino, C. Uthaipibull, S. E. Syed, I. T. Ling, T. Scott-Finnigan, and M. Blackman. 1999. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia 41:409-414.
16. Ismail, M. R., J. Orid, C. Menendez, P. J. Ventura, J. Aponte, E. Kahigwa, R. Hirt, A. Cardesa, and P. L. Alonso. 2000. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum. Pathol. 31:85-93.
17. Leopardi, O., W. Naughten, L. Salvia, M. Colecchia, A. Matteelli, A. Zucchi, A. Shein, J. A. Muchi, G. Carosi, and M. Ghione. 1996. Malaric placentas. A quantitative study and clinico-pathological correlations. Pathol. Res. Pract. 192:892-898.
18. Lindsay, S., J. Ansell, C. Selman, V. Cox, K. Hamilton, and G. Walraven. 2000. Effect of pregnancy on exposure to malaria mosquitoes. Lancet 355:1972.
19. Maubert, B., N. Fievet, G. Tami, M. Cot, C. Boudin, and P. Deloron. 1999. Development of antibodies against CSA-adherent Plasmodium falciparum in pregnant women. Infect. Immun. 67:5367-5371.
20. McGregor, I. A. 1984. Epidemiology, malaria and pregnancy. Am. J. Trop. Med. Hyg. 33:517-525.
21. Menendez, C. 1995. Malaria during pregnancy: a priority area of malaria research and control. Parasitol. Today 11:178-183.
22. Mvondo, J. L., M. A. James, A. J. Sulzer, and C. Campbell. 1992. Malaria and pregnancy in Cameroonian women. Naturally acquired antibody responses to asexual blood-stage antigens and the circumsporozoite protein of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 86:486-490.
23. O'Neil-Dunne, I., R. N. Achur, S. T. Agbor-Enoh, M. Valiyaveettil, R. S. Naik, C. F. Ockenhouse, A. Zhou, R. Megnekou, R. Leke, D. W. Taylor, and D. C. Gowda. 2001. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect. Immun. 69:7487-7492.
24. Ricke, C. H., T. Staalsoe, K. Koram, B. D. Akanmori, E. M. Riley, T. G. Theander, and L. Hvlid. 2000. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a pariety-dependent manner and block parasite adhesion to chondrointin sulfate. J. Immunol. 165:3309-3316.
25. Steketee, R. W., J. J. Wirima, A. W. Hightower, L. Slutsker, D. L. Heymann, and J. D. Breman. 1996. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am. J. Trop. Med. Hyg. 55:33-41.